You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-RNF8 antibody (ab4183)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-RNF8 antibody
See all RNF8 products (4) ...

Description

Rabbit polyclonal to RNF8

Specificity

This antibody recognises a single clean band representing RNF8.

Tested applications

ICC/IF, ICC, WBmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide conjugated to KLH derived from within residues 150 - 250 of Human RNF8.

(Peptide available as ab24680.)

Positive control

This antibody gave a positive signal in Hela Whole Cell, Hela Nuclear and HEK293 Whole Cell Lysates

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 1% BSA, PBS, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Anti-RNF8 antibody (ab4183)Western blot - Anti-RNF8 antibody (ab4183) image (enlarge)

  • Immunocytochemistry - Anti-RNF8 antibody (ab4183)Immunocytochemistry - Anti-RNF8 antibody (ab4183) image (enlarge)

  • Western blot - RNF8 antibody (ab4183)Western blot - RNF8 antibody (ab4183) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab4183 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

E3 ubiquitin-protein ligase required for assembly of repair proteins to sites of DNA damage. Catalyzes the 'Lys-63'-linked ubiquitination of histone H2A and H2AX. Following DNA double-strand breaks (DSBs), it is recruited to the sites of damage by ATM-phosphorylated MDC1, mediates the ubiquitination of histones H2A and H2AX, thereby promoting the formation of TP53BP1 and BRCA1 ionizing radiation-induced foci (IRIF). Promotes the formation of 'Lys-63'-linked polyubiquitin chains and functions with the specific ubiquitin-conjugating UBE2N/UBC13. Substrates that are polyubiquitinated at 'Lys-63' are usually not targeted for degradation. Enforces the G2/M DNA damage checkpoint. Controls the recruitment of UIMC1-BRCC3 (RAP80-BRCC36) and PAXIP1/PTIP to DNA damage sites following DNA double-strand breaks (DSBs). Ubiquitination of histone H2A requires UBE2N but not MMS2 (UBE2V2). May also ubiquitinate histone H2B. Catalyzes the 'Lys-63'-linked ubiquitination of PCNA. May be required for proper exit from mitosis after spindle checkpoint activation and may regulate cytokinesis. May play a role in the regulation of RXRA-mediated transcriptional activity. Not involved in RXRA ubiquitination by UBE2E2.

Tissue specificity

Ubiquitous. In fetal tissues, highest expression in brain, thymus and liver. In adult tissues, highest levels in brain and testis, lowest levels in peripheral blood cells.

Pathway

Protein modification; protein ubiquitination.

Sequence similarities

Belongs to the RNF8 family.
Contains 1 FHA domain.
Contains 1 RING-type zinc finger.

Developmental stage

Low levels at the G1-S boundary increase in intensity during S phase and until the end of the G2 phase. Abruptly decreases in late mitosis (at protein level). Barely detectable in anaphase.

Domain

The FHA domain specifically recognizes and binds ATM-phosphorylated MDC1 and Thr-4827 phosphorylated HERC2.

Post-translational
modifications

Autoubiquitinated through 'Lys-48' and 'Lys-63' of ubiquitin. 'Lys-63' polyubiquitination is mediated by UBE2N. 'Lys-29'-type polyubiquitination is also observed, but it doesn't require its own functional RING-type zinc finger.

Cellular localization

Nucleus. Midbody. Following DNA double-strand breaks, recruited to the sites of damage. During prophase, concomitant with nuclear envelope breakdown, localizes throughout the cell, with a dotted pattern. In telophase, again in the nucleus and also with a discrete dotted pattern in the cytoplasm. In late telophase and during cytokinesis, localizes in the midbody of the tubulin bridge joining the daughter cells. Does not seem to be associated with condensed chromosomes at any time during the cell cycle.

Target information above from: UniProt accessionO76064 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • C3HC4 type zinc finger protein antibody
  • E3 ubiquitin protein ligase RNF8 antibody
  • E3 ubiquitin-protein ligase RNF8 antibody
  • FLJ12013 antibody
  • KIAA0646 antibody
  • Ring finger protein (C3HC4 type) 8 antibody
  • Ring finger protein 8 antibody
  • RNF 8 antibody
  • RNF8 antibody
  • RNF8_HUMAN antibody
  • UBC13/UEV interacting ring finger protein antibody
see all

Anti-RNF8 antibody images:

  Western blot - Anti-RNF8 antibody (ab4183)

Western blot - Anti-RNF8 antibody (ab4183)

Lane 1 : Anti-RNF8 antibody (ab4183) at 1/500 dilution
Lane 2 : Anti-RNF8 antibody (ab4183) at 1/1000 dilution

Lane 1 : HeLa nuclear extract
Lane 2 : HeLa nuclear extract


Performed under reducing conditions.

Predicted band size : 55.5 kDa
Observed band size : 60 kDa (why is the actual band size different from the predicted?)

  Immunocytochemistry - Anti-RNF8 antibody (ab4183)

Immunocytochemistry - Anti-RNF8 antibody (ab4183)

HeLa cells incubated with ab4183 (1/200). The RNF8 antibody gives a relatively weak yet predominantly nuclear staining pattern in interphase nuceli. ab4183 staining is shown in green. The cells were counterstained with DAPI (red).

Kirk McManus, University of British Columbia

  Western blot - RNF8 antibody (ab4183)

Western blot - RNF8 antibody (ab4183)

All lanes : Anti-RNF8 antibody (ab4183) at 1 µg/ml

Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
Lane 2 : HeLa (Human epithelial carcinoma cell line) Nuclear Lysate
Lane 3 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate
Lane 4 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate with RNF8 peptide (ab24680) at 1 µg/ml
Lane 5 : HeLa (Human epithelial carcinoma cell line) Nuclear Lysate with RNF8 peptide (ab24680) at 1 µg/ml
Lane 6 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate with RNF8 peptide (ab24680) at 1 µg/ml

Lysates/proteins at 20 µg per lane.

Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Performed under reducing conditions.

Predicted band size : 55.5 kDa
Observed band size : 60 kDa (why is the actual band size different from the predicted?)


Exposure time : 3 minutes

References for Anti-RNF8 antibody (ab4183)

This product has been referenced in:

  • Suzuki Ket al. Creating localized DNA double-strand breaks with microirradiation. Nat Protoc 6:134-9 (2011). ICC/IF; Human.Read more (PubMed: 21293454) »
  • Ismail IHet al. BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J Cell Biol 191:45-60 (2010). WB, ICC/IF; Human.Read more (PubMed: 20921134) »

See all 7 publications for this product

Publishing research using ab4183? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"